Squarepoint
APVO icon

Squarepoint’s Aptevo Therapeutics APVO Stock Holding History

Squarepoint’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– -$25.1K – 3984
2023
Q4 		– Hold
0
– – – 3905
2017
Q4 		– Hold
0
– -$60K – 2065
2017
Q3 		– Hold
0
– – – 1552
2017
Q2 		– Hold
0
– – – 1474
2017
Q1 		– Hold
0
– – – 1421
2016
Q4 		– Hold
0
– – – 1579
2016
Q3 		– Hold
0
– – – 975

Other funds holding APVO

Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Truvestments Capital
Truvestments Capital Sarasota, Florida $673M AUM 55.24% 1-Year Est. Return